Advertisement
Advertisement
NDRA
ENDRA Life Sciences Inc. Common Stock
3.43
USDSponsored
-0.21
-5.77%
Mar 05, 16:00 UTC -5
Closed
After-Market
3.43
0.00
0.00%
NDRA Earnings Reports
Positive Surprise Ratio
NDRA beat 18 of 27 last estimates.
67%
Next Report
Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.25
Implied change from Q3 25 (Revenue/ EPS)
--
/-40.48%
Implied change from Q4 24 (Revenue/ EPS)
--
/-83.72%
ENDRA Life Sciences Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, NDRA reported earnings of -2.10 USD per share (EPS) for Q3 25, missing the estimate of -1.98 USD, resulting in a -5.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.25 USD, with revenue projected to reach -- USD, implying an decrease of -40.48% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Masimo Corporation
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.50
Actual
-Surprise
-
Teleflex Incorporated
Report Date
Feb 26, 2026 For Q4 25
Estimate
$3.77
Actual
$1.93
Surprise
-48.83%
Opko Health Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+42.28%
Integra LifeSciences Holdings
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.81
Actual
$0.83
Surprise
+1.68%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
OrthoPediatrics Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.43
Surprise
-25.36%
Delcath Systems Inc
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.05
Surprise
+20.51%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.05
Surprise
+29.97%
Anteris Technologies Global Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.59
Actual
-$0.74
Surprise
-24.18%
FAQ
What were ENDRA Life Sciences Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ENDRA Life Sciences Inc. Common Stock reported EPS of -$2.10, missing estimates by -5.58%, and revenue of $0.00, 0% as expectations.
How did the market react to ENDRA Life Sciences Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.46%, changed from $6.70 before the earnings release to $6.20 the day after.
When is ENDRA Life Sciences Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 30, 2026.
What are the forecasts for ENDRA Life Sciences Inc. Common Stock's next earnings report?
Based on 3
analysts, ENDRA Life Sciences Inc. Common Stock is expected to report EPS of -$1.25 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement